rs375713299
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001370466.1(NOD2):c.2186G>A(p.Arg729Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R729W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001370466.1 missense
Scores
Clinical Significance
Conservation
Publications
- Blau syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- inflammatory bowel disease 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370466.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NOD2 | NM_001370466.1 | MANE Select | c.2186G>A | p.Arg729Gln | missense | Exon 4 of 12 | NP_001357395.1 | ||
| NOD2 | NM_022162.3 | c.2267G>A | p.Arg756Gln | missense | Exon 4 of 12 | NP_071445.1 | |||
| NOD2 | NM_001293557.2 | c.2186G>A | p.Arg729Gln | missense | Exon 3 of 11 | NP_001280486.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NOD2 | ENST00000647318.2 | MANE Select | c.2186G>A | p.Arg729Gln | missense | Exon 4 of 12 | ENSP00000495993.1 | ||
| NOD2 | ENST00000300589.6 | TSL:1 | c.2267G>A | p.Arg756Gln | missense | Exon 4 of 12 | ENSP00000300589.2 | ||
| NOD2 | ENST00000641284.2 | n.2186G>A | non_coding_transcript_exon | Exon 4 of 6 | ENSP00000493088.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152246Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000996 AC: 25AN: 250968 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461566Hom.: 0 Cov.: 33 AF XY: 0.0000963 AC XY: 70AN XY: 727088 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2267G>A (p.R756Q) alteration is located in exon 4 (coding exon 4) of the NOD2 gene. This alteration results from a G to A substitution at nucleotide position 2267, causing the arginine (R) at amino acid position 756 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Regional enteritis;C5201146:Blau syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at